< p > the pharmaceutical industry: growth is expected to allow the policy is expected to turn for the better ,
abercrombie< br > < br >, the pharmaceutical industry 1-4 month profit downturn bottoms.1-4 pharmaceutical industry revenue growth of 28.95% growth rate of nearly 2 percentage points; total profit growth of 19.55% year-on-year decline.We think that the pharmaceutical industry profit growth to drop the main reason for the 2010 industry profit growth before tall hind low, rising costs and terminal product price fall.The current amplitude to glide trend has bottomed out, and the second half of the increase is likely to exceed the first half of the year.< br > < br > two, the pharmaceutical industry policy is expected to turn for the better.Shu pharmaceutical fraud may change the current tender policy only bid phenomenon, drug safety will be paid more attention to.Drug price downward trend will slow down,
doudoune moncler, part of a basic drug prices may increase the opportunity, drug is expected to take on the path of return value.The basic drug pricing will be good exclusive varieties.Effects of H1 pharmaceutical industry policy will reduce the pressure.< br > < br > three,
mercurial vapor, bio-medicine valuations have been close to the bottom of history.After 5 months of adjustment, the current biology medicine 25 times the dynamic valuation levels have been at a historic low level.Stock Jiancang opportunity knocks.< br > < br > four, medical industry grows big trend.The transformation of economic development mode, medical insurance system, improve and aging decided our country medical market expansion will be accelerated, medical industry grows big trend is irreversible.< br > < br > five, investment advice: Valuation near the bottom, a chance to show.Medical industry grows big trend has not changed, the pharmaceutical industry in 2011 has the potential to achieve revenue and profit growth of 25% above, and a former high-low after the characteristic, at present industry growth has bottomed trend.Pharmaceutical biotechnology valuation is close to the bottom of the history,
abercrombie france, stock investment opportunities appear.We are optimistic about the brand advantage and cost on ability of Chinese medicine health care products industry,
moncler, growth and has a significant cash subject matter may be a stock,
mercurial, the basic drug exclusive varieties as well as the major innovation concept stock investment opportunities.Recommended Pien Tze Huang,
moncler pas cher, Dong'e E-Jiao, Double-Crane Pharmaceutical, Bai pharmaceutical benefits, shares in animal husbandry,
louboutin, Hanyu industry, Chongqing beer, Hainan Haiyao, Changchun High-tech, pharmaceutical and Lansheng company.< br > < br > (Liao universal Huachuang securities) < / P > < p > a new round of the market to start, China's financial analyst meticulously researched, found a kill the wrong stocks have mysterious funds lurking, is about to fly,
doudoune moncler!Fill in the information,
louboutin pas cher, free!< / P > < p > < / P > < p > military plate market be triggered at any moment (unit) < / P > < p > military unit collective riots truth identification of soaring stock list < br > China military unit is ". " money; (unit) < / P > < p > < br > < br > stock tips the stock of knowledge; stock ABC internal market; gold stock terms; private equity fund shares; purchase stock software stock software; the main flow of funds; good bad thousands thousands of comments;
相关的主题文章：
more established West River cliff, cut Wushan rain, gorges. Goddess should be okay, shocked the world when the special.
